{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:29:46Z","timestamp":1749634186404},"reference-count":17,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1983,7]]},"abstract":"<jats:p content-type=\"fine-print\">\u2713 Within 4 weeks after definitive surgery, 91 patients with supratentorial glioblastomas and malignant astrocytomas were randomized to one of three treatment arms: Group 1 received radiotherapy alone; Group 2 received dibromodulcitol (DBD) during radiotherapy, and treatment was then continued with DBD; and Group 3 received DBD during radiotherapy, followed by combination chemotherapy of CCNU and DBD. No severe myelotoxicity occurred, but combined treatment with CCNU and DBD occasionally caused a transient myelosuppression. Statistical analysis of 84 evaluable patients showed a significantly longer survival period in those who received chemotherapy during and after irradiation. Median survival times in the three groups were 40, 57, and 60 weeks, respectively; the corresponding p value for Groups 2 and 3 was 0.025 and 0.0015. The ratio of patients surviving over 18 and 24 months was highest in Group 3. This study suggests that the administration of DBD during irradiation might have been the main factor in improving survival times.<\/jats:p>","DOI":"10.3171\/jns.1983.59.1.0106","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T18:16:27Z","timestamp":1241806587000},"page":"106-110","source":"Crossref","is-referenced-by-count":45,"title":["Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas"],"prefix":"10.3171","volume":"59","author":[{"given":"D\u00e9nes","family":"\u00c1fra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela","family":"Kocsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozsef","family":"Dobay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e1ndor","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Dibromodulcitol.","first-page":"189","article-title":"Treatment of gliomas by DBD","author":"\u00c1fra","year":"1982"},{"key":"b2","series-title":"Modern Neurosurgery","first-page":"137","article-title":"Treatment of supratentorial glioma recurrences with reoperation and chemotherapy","volume":"1","author":"\u00c1fra","year":"1982"},{"key":"b3","series-title":"Cancer","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/1097-0142(19810201)47:3<442::AID-CNCR2820470304>3.0.CO;2-1","article-title":"Clinical trials with the hexitol derivatives in the U.S.","volume":"47","author":"Chiuten","year":"1981"},{"key":"b4","series-title":"J R Stat Soc (B)","first-page":"187","article-title":"Regression models and life tables.","volume":"34","author":"Cox","year":"1972"},{"key":"b5","series-title":"Eur J Cancer","article-title":"The distribution of 3H-dibromodulcitol in the central nervous system of patients with brain tumor.","volume":"19","author":"Cset\u00e9nyi","year":"1983"},{"key":"b6","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1001\/jama.1979.03290450044023","article-title":"Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.","volume":"241","author":"Eagan","year":"1979"},{"key":"b7","series-title":"Oncology","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000225511","article-title":"Phase II studies of dianhydrogalactitol-based combination chemotherapy for recurrent brain tumors.","volume":"38","author":"Eagan","year":"1981"},{"key":"b8","series-title":"Dibromodulcitol.","first-page":"174","article-title":"Ten-year international clinical experience with DBD in the treatment of malignant diseases","author":"Eckhardt","year":"1982"},{"key":"b9","series-title":"Cancer Treat Rep","first-page":"841","article-title":"Uptake of labeled dianhydrogalactitol into human gliomas and nervous tissue.","volume":"61","author":"Eckhardt","year":"1977"},{"key":"b10","series-title":"Cancer Treat Rep","first-page":"1179","article-title":"Brain tumor chemotherapy: an evaluation of agents in current use for Phase II and III trials.","volume":"64","author":"Edwards","year":"1980"},{"key":"b11","series-title":"Eur J Cancer","first-page":"41","article-title":"Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma\u2014first evaluation.","volume":"12","year":"1976"},{"key":"b12","series-title":"J Neurosurg","first-page":"27","article-title":"Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study.","volume":"55","year":"1981"},{"key":"b13","series-title":"Biometrika","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/biomet\/52.1-2.203","article-title":"A generalized Wilcoxon test for comparing arbitrarily singly-censored samples.","volume":"52","author":"Gehan","year":"1965"},{"key":"b14","series-title":"J Am Stat Assoc","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958"},{"key":"b15","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","article-title":"Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.","volume":"49","author":"Walker","year":"1978"},{"key":"b16","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.","volume":"303","author":"Walker","year":"1980"},{"key":"b17","series-title":"Histological Typing of Tumours of the Central Nervous System.","article-title":"International histological classification of tumors, No. 21","author":"Z\u00fclch","year":"1979"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/59\/1\/article-p106.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/59\/1\/article-p106.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/59\/1\/article-p106.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T04:05:01Z","timestamp":1668312301000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/59\/1\/article-p106.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,7]]},"references-count":17,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/jns.1983.59.1.0106","relation":{},"ISSN":["0022-3085"],"issn-type":[{"value":"0022-3085","type":"print"}],"subject":[],"published":{"date-parts":[[1983,7]]}}}